Elevation Wealth Partners’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$906 Buy
60
+46
+329% +$803 ﹤0.01% 1264
2026
Q1
$269 Buy
+14
New +$304 ﹤0.01% 1058

Other funds holding TNDM

Elevation Wealth Partners's TNDM Position: Q2 2026 in Review

Elevation Wealth Partners increased its Tandem Diabetes Care (TNDM) stake by 329% in Q2 2026, buying an estimated $803 and bringing the position to 60 shares worth $906. The position accounts for ﹤0.01% of the portfolio, ranked #1264.

Elevation Wealth Partners first reported a position in TNDM in Q1 2026 and has held it in 2 quarters since. 56 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Elevation Wealth Partners held 60 shares of Tandem Diabetes Care worth $906 as of Q2 2026.
  • Elevation Wealth Partners bought 46 Tandem Diabetes Care shares in Q2 2026, an estimated $803.
  • Tandem Diabetes Care made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #1264 holding.
  • Elevation Wealth Partners first reported a position in Tandem Diabetes Care in Q1 2026 and has held it in 2 quarters since.
  • 56 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.